Europe

SHERIDAN, WYOMING - March 31, 2026 - Energy traders, compliance teams and market surveillance leaders in Europe face a more direct enforcement environment in 2026 as ACER sets the procedural framework for cross-border REMIT investigations and advances new reporting guidance under the revised regime. The 43rd edition of ACER's REMIT Quarterly centers on new Rules of Procedure for cross-border investigations, a practical step after EU legislators updated the REMIT framework in 2024 and gave ACER additional tasks, including the power to investigate cross-border cases. The quarterly also outlines ACER's stakeholder engagement plan for 2026, ongoing preparatory work on data reporting pending finalisation of the revised REMIT Implementing Regulation, and market surveillance updates tied to wholesale energy market integrity across the EU.

SHERIDAN, WYOMING - March 31, 2026 - Grinding manufacturers face a more data-driven operating model in 2026 as cooling lubricant management moves from a maintenance task into a direct lever for energy use, surface quality, uptime and scrap reduction. VDW highlights this shift through research and industrial practice around requirement-based coolant supply, where sensor data, standardized machine connectivity and cloud-based service platforms are used to stabilize grinding conditions and support more autonomous production.

SHERIDAN, WYOMING - March 31, 2026 - Danish gas tariff decisions in 2026 face a more demanding transparency test, with direct implications for how shippers, storage users and regulators evaluate network charges tied to upstream infrastructure. ACER's latest report reviews Energinet's proposed reference price methodology under the EU Network Code on Harmonised Transmission Tariff Structures and finds that while several core design elements align with the rules, the cost treatment of the upstream Baltic Pipe section cannot yet be fully assessed because key detail is missing.

SHERIDAN, WYOMING - March 31, 2026 - Manufacturing buyers and operations teams in northern Germany enter 2026 with a more concentrated venue for supplier discovery, cross-border networking and production planning as NORTEC runs in Hamburg from 3 to 5 February. The event is positioned as the first German trade fair of 2026 for manufacturers, and VDW frames it as an early indicator for the machine tool sector at a time when the manufacturing industry faces a challenging financial year.

NORTEC is marking its 20th year with a revised format for 2026. Messe Stuttgart says the show has been made more focused, with a compact three-day program and the full spectrum of production presented in Hall A4. The event brings together 175 national and international exhibitors and more than 40 program highlights, including panels and practical workshops, built with twelve network partners.

SHERIDAN, WYOMING - March 31, 2026 - Health organizations planning 2026 research participation in Europe gain a new route to influence project design, allocate in-kind resources, and support proposals without taking on full private-member status in the Innovative Health Initiative. MedTech Europe points to an 11 February 2026 webinar hosted by the IHI Office, focused on the contributing partner category for organizations that are not affiliated with an IHI private industry member, as well as organizations affiliated with a private member that need to understand how contributing partners can support proposals. The session is positioned around practical participation questions rather than broad program promotion, including eligibility, application steps, contribution rules, and common mistakes.

SHERIDAN, WYOMING - April 4, 2026 - Research teams and organizations working on animal feed and flour milling innovation now have a structured path to external financing through the Victam Foundation's 2026 Call for Funding, with final project selections and award decisions scheduled for completion by early June 2026 at Victam International in Utrecht, The Netherlands.

Funding cycle overview

The Victam Foundation opened its 2026 Call for Funding submission window on September 12, 2025, accepting project proposals through January 31, 2026. The call targets researchers, organizations, and innovators developing projects that advance the animal feed and flour milling industries. There are no submission fees, and proposals must be submitted via the foundation's online requesting form. Applications must include a detailed project description and an expected budget; the foundation reserves the right to request additional documentation where necessary.

SHERIDAN, WYOMING - March 31, 2026 - European hospitals evaluating 2026 imaging, intervention, and workforce plans now have a new validation pathway for AI-assisted neurovascular and oncology procedures as the SHERPA consortium starts seven clinical studies focused on workflow automation, precision support, and staff-pressure reduction in minimally invasive care. The four-year project has a total budget of EUR 21.5 million, is coordinated by Philips, and is co-funded by the EU Innovative Health Initiative and industry partners. Its work targets minimally invasive treatment workflows for brain aneurysms, liver tumors, and lung biopsy settings where specialized expertise is limited and procedure complexity is high.

SHERIDAN, WYOMING - March 13, 2026 - ANGA COM has published the conference agenda for its 2026 exhibition and conference, scheduled for May 19-21 in Cologne, Germany, with a program centered on broadband, media and connectivity. The event will feature more than 50 panels and over 200 speakers, including a strong CEO presence from telecom and media companies. The updated agenda matters for operators, vendors, municipalities and investors because it concentrates on network strategy, media business priorities and policy issues that directly affect deployment, service delivery and market positioning. It also expands the practical component of the event through new round tables and a municipalities-focused theme day.

SHERIDAN, WYOMING - December 19, 2025 - Voyager Therapeutics is laying off 30 employees after partner Novartis discontinued two undisclosed discovery-stage programs under the companies' gene therapy collaboration, underscoring how quickly platform-driven R&D bets can be reprioritized even inside marquee pharma partnerships.

Commercial partnerships can shift overnight
Voyager disclosed last month that Novartis had stepped away from two early programs tied to their ongoing relationship, without naming the assets or detailing the rationale. The biotech framed the change as manageable, stating that Novartis' decision will "not impact Voyager's cash runway guidance." Still, the workforce reduction signals that operational resets often follow partnership scope changes-especially when programs are preclinical and the near-term value is concentrated in a smaller set of advancing assets.

SHERIDAN, WYOMING - December 19, 2025 - Merck said the EMA's CHMP has recommended approval of an expanded European indication for WINREVAIR (sotatercept) in adults with pulmonary arterial hypertension (PAH), a move that-if confirmed by the European Commission-could broaden use to include WHO Functional Class (FC) IV patients and strengthen the product's positioning around morbidity and mortality benefit.